Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy

The incidence of malignant melanoma is rising worldwide and survival for metastatic disease is still poor. Recently, new treatment options have become available. Still, predictive biomarkers are needed to optimise treatment for this patient group. In this study, we investigated the predictive value...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuster, Cornelia, Akslen, Lars A, Stokowy, Tomasz, Straume, Oddbjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317286/
https://www.ncbi.nlm.nih.gov/pubmed/30225999
http://dx.doi.org/10.1002/cjp2.116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317286/
https://www.ncbi.nlm.nih.gov/pubmed/30225999
http://dx.doi.org/10.1002/cjp2.116

Ejemplares similares